COMMUNIQUÉS West-GlobeNewswire

Transactions under Novozymes’ stock buyback program
29/07/2019
Please read the full announcement in the attached PDF Attachment 2019_25_Stock_Buybackprogram_EN
Ziopharm Oncology Announces $45 Million Warrant Exercise by Existing Shareholders in a Private Placement
29/07/2019
Provides capital to fund operations into 2021; warrant exercise in advance of November 2023 expiration BOSTON, July 29, 2019 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (“Ziopharm”) (Nasdaq: ZIOP), today announced that [...]
Allogene Therapeutics to Report Second Quarter 2019 Financial Results on August 7, 2019
29/07/2019
Conference Call and Webcast Scheduled for 5:30 AM PT/8:30 AM ET SOUTH SAN FRANCISCO, Calif., July 29, 2019 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company [...]
Turning Point Therapeutics Appoints Biotechnology Investment Banker Yi Larson as Executive Vice President and Chief Financial Officer
29/07/2019
SAN DIEGO, July 29, 2019 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing novel drugs to address treatment resistance, today named Yi Larson as executive vice [...]
TRACON Pharmaceuticals to Participate in Wells Fargo Securities 2019 Biotech Corporate Access Day
29/07/2019
SAN DIEGO, July 29, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, [...]
VBI Vaccines Announces Dosing of First Recurrent GBM Patient in Part B of Ongoing Phase 1/2a Study of VBI-1901
29/07/2019
— Part B of the study, a subsequent extension of the optimal dose from Part A, to enroll 10 first-recurrent GBM patients — Initial immunologic data from Part B expected around year-end 2019 — Expanded immunologic data [...]
TYME Technologies Announces New Collaboration with NYU Langone to Advance TYME’s Cancer Metabolism-Based Therapy, SM-88
29/07/2019
NEW YORK, July 29, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company, announced a new research collaboration with NYU Langone Health to advance the development of [...]
AMAG Pharmaceuticals to Host Second Quarter 2019 Financial Results Conference Call and Webcast on Wednesday, August 7, 2019 at 8:00 a.m. ET
29/07/2019
WALTHAM, Mass., July 29, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that its second quarter 2019 financial results will be released on Wednesday, August 7, 2019 before the U.S. [...]
Aggressive Growth by Commercial Medical Device Reprocessors Saved Hospitals and Health Systems Nearly $500M Last Year, According to 20th Anniversary Report from Association of Medical Device Reprocessors
29/07/2019
Commercial reprocessing industry saved over $471 million for 8,885 hospitals and surgical centers in 2018 Hospital uptake of commercial medical device reprocessing doubled yearly for the last 20 years Welcomed [...]
Biotricity Audited Year-End Results Demonstrate Execution of Commercial Growth Plans
29/07/2019
REDWOOD CITY, Calif., July 29, 2019 (GLOBE NEWSWIRE) -- Biotricity Inc. ( OTCQB : BTCY ), a medical diagnostic and consumer healthcare technology company, today announced that it has completed its 10-K filing for the [...]
H-CYTE Bolsters Board of Directors With Appointment of Dr. Andre Terzic to Board of Directors
29/07/2019
TAMPA, Fla., July 29, 2019 (GLOBE NEWSWIRE) -- H-CYTE Inc. (OTCQB: HCYT) (“H-CYTE” or the “Company”), the owner and operator of innovative medical technology products and services including Lung Health Institute , today [...]
Athenex, Inc. to Report Second Quarter 2019 Earnings Results on August 7, 2019
29/07/2019
BUFFALO, N.Y., July 29, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
Rhythm Pharmaceuticals Announces Positive Opinion by the European Medicines Agency on Orphan Drug Designation for Setmelanotide for the Treatment of Bardet-Biedl Syndrome
29/07/2019
BOSTON, July 29, 2019 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq:RYTM), a biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare genetic [...]
Ascendis Pharma A/S Announces Participation in August Investor Conferences
29/07/2019
COPENHAGEN, Denmark, July 29, 2019 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to address unmet medical needs, today announced [...]
Avinger Announces Pantheris SV Limited Launch and Successful Treatment of First Patients in the United States
29/07/2019
REDWOOD CITY, Calif., July 29, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for [...]
Appendix 4C– June 2019 Quarter
29/07/2019
Positive results from two prostate cancer trials Phase 2 trial design gaining momentum Investigational New Drug Application to be submitted to FDA in Q3 2019 Pipeline developing based on drug discovery program Board [...]
Spring Bank Announces FDA Acceptance of IND Application for SB 11285, an IV-Administered STING Agonist, for the Treatment of Advanced Solid Tumors
29/07/2019
IV-Administered SB 11285 Phase 1 Trial Planned to Initiate in Coming Weeks HOPKINTON, Mass., July 29, 2019 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company [...]
Crinetics Pharmaceuticals to Receive Final Award of SBIR Grant from NIH for Congenital Hyperinsulinism
29/07/2019
SAN DIEGO, July 29, 2019 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for [...]
Alkahest Phase 2a Study AKST4290-202 in Refractory Neovascular AMD meets Primary and Secondary Endpoints
29/07/2019
SAN CARLOS, Calif., July 29, 2019 (GLOBE NEWSWIRE) -- Alkahest, Inc., a clinical stage biotechnology company focused on developing transformative therapies to treat age-related diseases, announced that its phase 2a [...]

Pages